BL PHARMTECH CORP.

Financials BL Pharmtech Corp.

Equities

A065170

KR7065170003

Food Processing

End-of-day quote Korea S.E. Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
487 ^KRW	+0.62%		-2.60%	-3.56%

28/03	Youngchul Park completed the acquisition of 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation.	CI
20/03	BL Pharmtech Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Valuation

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Capitalization ¹	95,150	87,904	1,45,716	1,16,549	55,605	44,929
Enterprise Value (EV) ¹	85,115	88,881	1,77,282	1,35,691	92,788	35,984
P/E ratio	66.8 x	-7.42 x	-6.92 x	-5.69 x	-4 x	-302 x
Yield	-	-	-	-	-	-
Capitalization / Revenue	1.09 x	1.49 x	2.22 x	1.38 x	0.69 x	1.83 x
EV / Revenue	0.97 x	1.51 x	2.7 x	1.61 x	1.15 x	1.47 x
EV / EBITDA	19 x	-13.7 x	378 x	-925 x	183 x	-5.74 x
EV / FCF	-7.98 x	-4.85 x	-8.07 x	32.4 x	-11.5 x	4.96 x
FCF Yield	-12.5%	-20.6%	-12.4%	3.08%	-8.72%	20.2%
Price to Book	1.59 x	1.93 x	2.2 x	1.99 x	1.65 x	1.43 x
Nbr of stocks (in thousands)	61,585	61,904	86,994	88,969	88,969	88,969
Reference price ²	1,545	1,420	1,675	1,310	625.0	505.0
Announcement Date	20/03/19	17/03/20	17/03/21	22/03/22	22/03/23	20/03/24

¹KRW in Million²KRW

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Net sales ¹	87,686	58,869	65,691	84,440	80,593	24,525
EBITDA ¹	4,474	-6,497	469.5	-146.7	506.1	-6,271
EBIT ¹	2,558	-8,087	-2,063	-3,595	-3,118	-7,119
Operating Margin	2.92%	-13.74%	-3.14%	-4.26%	-3.87%	-29.03%
Earnings before Tax (EBT) ¹	1,409	-16,597	-14,357	-20,570	-13,199	-13,856
Net income ¹	1,302	-11,820	-17,947	-20,211	-13,903	-148.8
Net margin	1.48%	-20.08%	-27.32%	-23.94%	-17.25%	-0.61%
EPS ²	23.12	-191.3	-242.1	-230.2	-156.3	-1.673
Free Cash Flow ¹	-10,671	-18,341	-21,960	4,183	-8,087	7,260
FCF margin	-12.17%	-31.16%	-33.43%	4.95%	-10.03%	29.6%
FCF Conversion (EBITDA)	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-
Dividend per Share	-	-	-	-	-	-
Announcement Date	20/03/19	17/03/20	17/03/21	22/03/22	22/03/23	20/03/24

¹KRW in Million²KRW

Estimates

Balance Sheet Analysis

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Net Debt ¹	-	977	31,566	19,142	37,182	-
Net Cash position ¹	10,034	-	-	-	-	8,945
Leverage (Debt/EBITDA)	-	-0.1504 x	67.24 x	-130.4 x	73.47 x	-
Free Cash Flow ¹	-10,671	-18,341	-21,960	4,183	-8,087	7,260
ROE (net income / shareholders' equity)	2.39%	-28.4%	-26.8%	-29.1%	-25.6%	-37.9%
ROA (Net income/ Total Assets)	1.86%	-5.24%	-1.15%	-1.7%	-1.67%	-5.99%
Assets ¹	70,068	2,25,654	15,54,941	11,90,441	8,34,919	2,484
Book Value Per Share ²	973.0	734.0	760.0	657.0	380.0	353.0
Cash Flow per Share ²	515.0	367.0	142.0	244.0	56.50	119.0
Capex ¹	4,421	23,464	17,626	587	1,708	312
Capex / Sales	5.04%	39.86%	26.83%	0.7%	2.12%	1.27%
Announcement Date	20/03/19	17/03/20	17/03/21	22/03/22	22/03/23	20/03/24

¹KRW in Million²KRW

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
BL PHARMTECH CORP.	-3.56%	31.64M
ZHEJIANG NHU COMPANY LTD.	+16.80%	8.43B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+15.02%	6.82B
THE SIMPLY GOOD FOODS COMPANY	-4.77%	3.77B
BYHEALTH CO., LTD	-6.75%	3.74B
XIAMEN KINGDOMWAY GROUP COMPANY	+4.41%	1.44B
HERBALIFE LTD.	-30.34%	1.06B
SIRIO PHARMA CO., LTD.	+20.28%	1.04B
USANA HEALTH SCIENCES, INC.	-12.85%	890M
JAMIESON WELLNESS INC.	-15.63%	812M

Special Foods & Wellbeing Products

Stock Market
Equities
A065170 Stock
Financials BL Pharmtech Corp.

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW